GLUCOLATE Trademark

Trademark Overview

On Monday, May 22, 2023, a trademark application was filed for GLUCOLATE with the United States Patent and Trademark Office. The USPTO has given the GLUCOLATE trademark a serial number of 98008045. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, March 31, 2025. This trademark is owned by Aquariun Investments LLC. The GLUCOLATE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Pharmaceutical preparations for treating diabetes
glucolate

General Information

Serial Number98008045
Word MarkGLUCOLATE
Filing DateMonday, May 22, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, March 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements

Goods and ServicesAnti-diabetic pharmaceuticals; Anti-diabetic preparations; Pharmaceutical preparations for treating diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 23, 2023
Primary Code005
First Use Anywhere DateSunday, June 9, 2024
First Use In Commerce DateSunday, June 9, 2024

Trademark Owner History

Party NameAquariun Investments LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSheridan, WY 82801
Party NameAquariun Investments LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSheridan, WY 82801

Trademark Events

Event DateEvent Description
Thursday, May 25, 2023NEW APPLICATION ENTERED
Friday, June 23, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 13, 2024ASSIGNED TO EXAMINER
Wednesday, February 14, 2024NON-FINAL ACTION E-MAILED
Wednesday, February 14, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, September 21, 2024USE AMENDMENT FILED
Saturday, September 21, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, November 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 5, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 10, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, March 6, 2025DIVISIONAL REQUEST RECEIVED
Thursday, March 6, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 10, 2024NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 31, 2025DIVISIONAL PROCESSING COMPLETE
Monday, March 31, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 31, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, March 31, 2025REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Monday, March 31, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 31, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

glucolate anti preparations diabetic diabetes treating pharmaceutical pharmaceuticals